ArticleChemical & biomedical imaging2026
A Molecular Hybrid for Double Stepwise Nitric Oxide Photorelease with Double Fluorescence Readout in Living Cells.
Article in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Red light-mediated stepwise nitric oxide releaseChemical science · 2026Article
- Phototherapeutic β-Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin.Biomacromolecules · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The strict dependence of the multifaceted biological effects of nitric oxide (NO) on the generation site and dose demands precise spatiotemporal control of its delivery. Light-activatable NO precursors enable this requirement by allowing for the appropriate localization of the excitation light source on the area of interest and regulation of the light dose. However, monitoring the NO released in living cells with the aid of noninvasive fluorescence techniques, without the use of additional NO probes, is very challenging for the bioapplications of this inorganic free radical. We report herein the design, synthesis, characterization, and biological validation of a molecular hybrid consisting of two chromogenic nitroso-derivatives covalently joined through a flexible alkyl spacer, which can release two NO molecules exclusively under visible light input through a stepwise mechanism accompanied by a double fluorescence readout. Specifically, the two distinct NO release processes are paralleled by a turn-on and turn-off of the green fluorescence of the corresponding stable coproducts, respectively, which act as optical NO reporters. This feature permits monitoring of the two individual steps of NO photouncaging in real time by fluorescence spectroscopy. Proof-of-principle fluorescence microscopy experiments demonstrate that, not trivially, the photochemical properties of the hybrid are well-preserved in living cancer cells, where the stepwise release of NO can be imaged in real time without the use of additional chemical probes. This makes the present compound an intriguing candidate for fundamental and potential applicative research studies, where the short- and long-term release of spatiotemporally controlled NO delivery, associated with its direct optical detection, is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.